Taurine modulates arginine vasopressin-mediated regulation of renal function.
Taurine has been implicated in the regulation of arginine vasopressin (AVP) secretion, and we have previously shown altered renal excretory function in the taurine-depleted rat. To further elucidate the role of taurine in AVP-mediated renal responses, the effects of an antagonist for renal AVP receptors were examined in four groups of conscious rats: control, taurine-supplemented, taurine-depleted, and taurine-repleted. Control and taurine-supplemented rats displayed similar and significant AVP receptor antagonist-induced elevations in fluid excretion, sodium excretion, and free water clearance but a marked reduction in urine osmolality. These effects are consistent with inhibition of endogenous AVP activity. By contrast, in the taurine-depleted rats, the magnitude and the time course of drug-induced renal excretory responses lagged behind those of the control and taurine-supplemented groups. Further, baseline urine osmolality was significantly higher in the taurine-depleted compared with the control or taurine-supplemented groups. However, after administration of the antagonist, taurine-depleted rats manifested a delayed but more marked reduction in urine osmolality, thereby eliminating the baseline differential that existed between the taurine-depleted rats and control or taurine-supplemented groups. Consistent with these observations, plasma AVP was significantly increased in the taurine-depleted compared with the control rats. Interestingly, taurine repletion shifted all responses closer to the control group. Analysis of the data suggests that the effect of the antagonist on renal excretory function is related primarily to altered tubular reabsorption activity. These observations suggest that taurine modulates renal function, and, thereby, body fluid homeostasis, through an AVP-dependent mechanism.
Mozaffari
M S
MS
Department of Oral Biology and Maxillofacial Pathology, Medical College of Georgia, Augusta 30912-1128, USA. Mmozaffa@mail.mcg.edu
Schaffer
D
D
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000097:blood / Q000502:physiology*; D004573:Electrolytes / Q000652:urine; D005919:Glomerular Filtration Rate / Q000187:drug effects* / Q000502:physiology; D008297:Male; D051381:Rats; D011921:Rats, Inbred WKY; D017483:Receptors, Vasopressin / Q000502:physiology; D013654:Taurine / Q000008:administration & dosage* / Q000097:blood / Q000652:urine
D065092:Antidiuretic Hormone Receptor Antagonists; D004573:Electrolytes; D017483:Receptors, Vasopressin; D001127:Arginine Vasopressin; D013654:Taurine